- Home
- Site Contents
- Our Founder
- Governance
- Faculty
- Strategic Plan
- Core Values
- Resources
- Programs - Research
- Programs - Education
- Programs - Service
- Clinical Trials
- Other Activities
- Press Releases 1980-1999
- Press Releases 2000-2009
- Press Releases 2010-2014
- Press Releases 2015-2019
- Press Releases 2020-2024
- Press Releases 2025-2029
- Blogs
- Podcasts
- LinkedIn Posts
- Conferences 2013-2017
- Conferences 2018
- Conferences 2019
- Conferences 2020
- Conferences 2021
- Conferences 2022
- Conferences 2023
- Conferences 2024
- Conferences 2025
- Patents
- Books & Monographs
- Book Contributions -1
- Book contributions -2
- Refereed Articles - 1
- Refereed Articles -2
- Refereed Articles - 3
- Refereed Articles - 4
- Abstracts 2013-2017
- Abstracts 2018-2019
- Abstracts 2020-2025
- Philanthropy
- Privacy Policy
REFEREED ARTICLES - 3
2019
A. L. Fymat, Dementia: A Review, Journal of Clinical Psychiatry and Neuroscience 1(3):27-34 (January 2019).
A. L. Fymat, Alpha Particles Irradiation: A Paradigm Change in Cancer Brachytherapy, Journal of Cancer Prevention and Current Research 10(1):30-31, doi: 10.15406/jcpcr2019-10.00386. https://medcraveonline.com/JCPCR/JCPCR-10-00386.pdf (February 2019).
A.L. Fymat, Is Alzheimer a Runaway Autoimmune Disease? And How to Cure It? Proceedings of the European Union Academy of Sciences, 2018 Newsletter, pages 379-383.
A.L. Fymat, The Pathogenic Brain, Journal of Current Opinions in Neurological Science 3(2);669-671, 2019. ISSN: 2575-5447.(April 2019).
A. L. Fymat, On the Pathogenic Hypothesis of Neurodegenerative Diseases, Journal of Clinical Research in Neurology 2(1):1-7, 2019. (May 2019).
A. L. Fymat, Dementia with Lewy Bodies: A Review, Journal of Current Opinions in Neurological Science 4(1);15-32. ISSN: 2575-5447. (July 2019).
A. L. Fymat, Our Two Interacting Brains – Etiologic Modulations of Neurodegenerative and Gastroenteric Diseases, Journal of Current Opinions in Neurological Science 4(2):50-54 (October 2019).
A. L. Fymat, What do we Know about Lewy Body Dementias? Journal of Psychiatry and Psychotherapy (Editorial) 2(1)-013:1-4. doi:10.31579/JPP.2019/018 (October 2019).
A. L. Fymat, Electromagnetic Therapy for Neurological and Neurodegenerative Diseases: I. Peripheral Brain Stimulations. Open Access Journal of Neurology and Neurosurgery 12(2):30-47. doi:10.19080/OAJNN.2019.12.555833(December 2019).
A. L. Fymat, Viruses in the brain...? Any connections to Parkinson's and other neurodegenerative diseases? Proceedings of the European Union Academy of Sciences, 2019 Newsletter, pages 249-252.
Y. A. Meunier. A public health program and others for about 10,000 villagers in the Kutubu area of Papua New Guinea (PNG). Community Medicine and Health Education Research 1(1):25-30 https://www.cmher.com/index.php/cmher/article/view/24/15
2020
A. L. Fymat, Recent Research Developments in Parkinson's Disease, Current Opinions in Neurological Science 5(1):12-30, ISSN: 2575-5447.(February 2020).
A. L. Fymat, Neuroradiology and its Role in Neurodegenerative Diseases, Journal of Radiology and Imaging Science 1(1):1-14 (February 2020).
A. L. Fymat, Electromagnetic Therapy for Neurological and Neurodegenerative Diseases: II. Deep Brain Stimulation. Open Access Journal of Neurology and Neurosurgery 13(1):1-17. doi: 19080/OAJNN.2020.13.555855(29 March 2020).
A. L. Fymat, Nanobiotechnology-based Drugs for the Treatment of Neurological Disorders, Journal of Pharmaceutical Bioprocessing 8(3):1-3, 2020.
A. L. Fymat, Global Market Analysis on Nanomedicine and Drug Delivery Systems, American Journal of Advanced Drug Delivery.
A. L. Fymat, Is Alzheimer's an Autoimmune Disease Gone Rogue? The Role of Brain Immunotherapy, Journal of Clinical Research in Neurology 3(2):1-3, November 2020.
A. L. Fymat, Alzheimer's: What do we Know about the Disease and what can be done about it? EC Journal of Psychology & Psychiatry 9(11):69-74, 2020. October 1, 2020.
A. L. Fymat, Alzheimer's: Will there ever be a Cure? Journal of Clinical Psychiatry and Neuroscience 3(4): 1-5, November 2020.
2021
A. L. Fymat, Infection-mediated Heart Disease – Case of Lyme Carditis, EC Journal of Emergency Medicine and Critical Care 5(1):37-38, January 2021.
A. L, Fymat, Parkinson's: What is known about the disease and what can be done about it? Journal of Clinical Research in Neurology 3(2):1-12, December 2020.
A. L. Fymat, Dementia: Should we reorient our approach to treatment? EC Journal of Psychology & Psychiatry 9(12):1-3, December 2020.
A, L. Fymat, On the symbiosis between our two interacting brains, Proceedings of the European Union Academy of Sciences, 2021.
A. L. Fymat, Dementia – What is its causal etiology? International Journal of Neuropsychology and Behavioral Sciences 1(1):19-22 )23 December 2020).
A. L. Fymat, On SARS COV-2 neuropsychiatric dysfunctions and sequelae, Journal of Current Opinions in Neurological Sciences6(1):89-93, 2021
A. L. Fymat, Paradigm for Pandemic Prediction and Prevention, International Journal of Applied Mathematics & Computation 9:27-42, 2021.
A. L. Fymat, Major recent developments in cancer treatment, Cancer Therapy & Oncology International Journal (Editorial) 18(2):1-3. doi: 10.19080/CTOJI.2021.18.555982.
A. L. Fymat, Magnetic Resonance Imaging Contrast Agents – Issues of Concern, Safety, and Efficacy, AS Medical Sciences Journal (submitted 3/4/2021) Reference ID: ASMS-21-RW-104
A. L. Fymat, Paradigm for Pandemic Prediction and Prevention, Proc. European Union Academy of Sciences Pandemics (e2021 Symposium), Universal Journal of Mathematics & Computation 9:27-42, 2021.
A. L. Fymat, Nanobiotechnology Roles in Brain Cancer Treatments, United Journal of Nanotechnology and Medicine 2(1): 1-8, 2021.
A. L. Fymat, Cancer Treatment: From Immunotherapy to Gene Therapy and Beyond, Journal of Cancer Research & Medicine, Editorial 2(003):1-3 (June 2021).
A. L. Fymat, Could COVID-19 Cause Lasting Psychoneurological Effects? Current Opinions in Neurological Science 6(1):94-100. (23 September 2021).
A. L. Fymat, On Potentially Reversible Forms of Dementia, Journal of Current Opinions in Neurological Science 6(1):101-8, 2021. (November 2021).
A. L. Fymat, Dementia – Eliminating its Potentially Reversible Forms, Proc. European Union Academy of Sciences. Pages 270-277 (2021).
Y. A. Meunier, From Nigeria to Singapore: A knack for challenges. Physician Outlook Magazine, 31 August 2021.https://www.physicianoutlook.com/articles/global-health-nigeria-singapore-having-knack-chall
2022
A. L. Fymat, Nanobiotechnology: Unique Role in Combating the COVID-19 Pandemic. United Journal of Nanotechnology and Pharmaceutics 2(2): (January 2022).
Y. A. Meunier, Global Health. What Stands Behind the Name, A Global Mess?, Primera Scientific Medicine and Public health, 1 (1):27-29 (August 2022).
Y. A. Meunier, The COVID-19 pandemic: An opportunity to assess the global health status. International Journal of Collaborative Research on Internal Medicine and Public Health 14(1)1-2, 2022.
Y. A. Meunier, Global Health. What Stands Behind the Name, A Global Mess? PriMera Scientific Medicine and Public Health 1(1):1-3, 2022.
https://primerascientific.com/pdf/psmph/PSMPH-01-005.pdf
A. L. Fymat, Global Health - Major Issues Revealed by COVID-19, Proceedings of the European Union Academy of Sciences, 2022 Newsletter, pages 39-47 (15 September 2022).
A. L. Fymat, Alzheimer's Disease: A Path to a Cure, Journal of Neurology and Psychology Research 3(1):1-15, October 2022.
A. L. Fymat, Alzheimer's Disease: A Path to a Cure, Current Opinions in Neurological Science,3(1):1-16, November 2022.
A. L. Fymat, Major Global Health Issues During the COVID-19 Pandemic - Evidence-Based Medicine, Journal of Current Emergency Medicine Reports 2(2):1-16, October 2022.
A. L. Fymat, Global Health - Major Issues Revealed by COVID-19, Proceedings of the European Union Academy of Sciences, 2022 Newsletter, pages 35-42,
A. L. Fymat, Alzheimer's Disease: A Path to a Cure, Journal of Neurology and Psychology Research 3(1):1-15, October 2022.
A. L. Fymat, Alzheimer's Disease: A Path to a Cure, Current Opinions in Neurological Science,3(1):1-16, November 2022.